My research focuses on the treatment of obesity and its metabolic complications. During the M.D. and Ph.D. program, I have studied specific nutritional and pharmacological approaches to treat obesity, analyzing their influence on appetite-regulating hormones and central control of appetite and, ultimately, their effect on metabolic outcomes such as dyslipidemia and cardio-metabolic risk factors. Currently, my research focuses on several funded clinical research projects on the effect of diet on appetite-regulating hormones in overweight/obesity and T2D, on the nutraceutical approach to reduce insulin resistance and glycemic variability using D-chiro-inositol, and, conclusively, on the cardiometabolic outcome of metabolic and endoscopic surgery.
My research focuses on the treatment of obesity and its metabolic complications. During the M.D. and Ph.D. program, I have studied specific nutritional and pharmacological approaches to treat obesity, analyzing their influence on appetite-regulating hormones and central control of appetite and, ultimately, their effect on metabolic outcomes such as dyslipidemia and cardio-metabolic risk factors. Currently, my research focuses on several funded clinical research projects on the effect of diet on appetite-regulating hormones in overweight/obesity and T2D, on the nutraceutical approach to reduce insulin resistance and glycemic variability using D-chiro-inositol, and, conclusively, on the cardiometabolic outcome of metabolic and endoscopic surgery.